MARCHF8 and HIV-1 infection: Their work indicated the MARCH8 222AxxL225 mutant failed to inhibit HIV-1 infection but potently restricted VSV-G/LCMV-GP pseudotyped virions infectivity [9,34], pointing out that this type of MARCH8 anti-HIV-1 CTI mode was TBM-dependent.